<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="26" left="55" width="517" height="27" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="601" left="238" width="187" height="12" font="1">http://www.epitomics.com/products/produc</text>
<text top="613" left="238" width="43" height="12" font="1">t_info/194</text>
<text top="77" left="138" width="38" height="12" font="1">12/31/11</text>
<text top="340" left="95" width="323" height="12" font="1">A synthetic peptide corresponding to residues in C-terminus of human ELK-1  </text>
<text top="352" left="95" width="343" height="12" font="1">was used as immunogen. The antibody does not cross-react with other ETS family  </text>
<text top="364" left="95" width="44" height="12" font="1">members. </text>
<text top="484" left="150" width="31" height="12" font="1">Human</text>
<text top="520" left="178" width="89" height="12" font="2">Immunoprecipitation</text>
<text top="134" left="326" width="92" height="12" font="1">sglandt@stanford.edu</text>
<text top="134" left="83" width="61" height="12" font="1">Stephen Landt</text>
<text top="214" left="121" width="124" height="12" font="1">Elk-1 (C-term) (ELK1) antibody</text>
<text top="214" left="339" width="108" height="12" font="1">ELK1 (EntrezGeneID 2002)</text>
<text top="170" left="230" width="29" height="12" font="1">Snyder</text>
<text top="255" left="239" width="41" height="12" font="1">Epitomics</text>
<text top="484" left="361" width="27" height="12" font="1">Rabbit</text>
<text top="300" left="395" width="48" height="12" font="1">YG030402C</text>
<text top="300" left="215" width="29" height="12" font="1">1277-1</text>
<text top="520" left="395" width="54" height="12" font="2">IP-Mass Spec</text>
<text top="561" left="141" width="30" height="12" font="2">Affinity</text>
<text top="561" left="356" width="43" height="12" font="2">Polyclonal</text>
<text top="412" left="95" width="320" height="12" font="1">Elk-1 is a transcription factor that is part of the ets oncogene superfamily (1).  </text>
<text top="424" left="95" width="365" height="12" font="1">Elk-1 forms a ternary complex with the serum response factors, SRE and SRF, mediating  </text>
<text top="436" left="95" width="372" height="12" font="1">gene activity in response to serum and growth factors (2). Activation by several mitogen-  </text>
<text top="448" left="95" width="378" height="12" font="1">activated protein kinases (Erk1 and Erk2) mediates the immediate early responses of the c-  </text>
<text top="460" left="95" width="385" height="12" font="1">fos promoter to growth factors and other stimuli (3,4). Serines 383 and 389 in the C-terminal  </text>
<text top="472" left="95" width="290" height="12" font="1">region are the preferred sites for phosphorylation-induced activation. </text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="43" left="125" width="394" height="12" font="1">Comment: We observe one major band of ~65kD in all cell lines assayed (Panel A).  This band is </text>
<text top="55" left="125" width="375" height="12" font="1">immunoprecipitated from K562 cells at very high efficiency and is absent in an IgG control </text>
<text top="67" left="125" width="409" height="12" font="1">immunoprecipitation. (Panel B and second validation assay).   The major band migrates somewhat </text>
<text top="79" left="125" width="429" height="12" font="1">slower than predicted for ELK1 (~44kD), but this is generally observed with ELK1 (see product literature </text>
<text top="91" left="125" width="418" height="12" font="1">for this and other commercially available antibodies).  Moreover, this band was confirmed to contain </text>
<text top="103" left="125" width="414" height="12" font="1">ELK1 by mass spectrometry (see second validation assay).  Therefore, 1277-1 meets this criterion for </text>
<text top="115" left="125" width="46" height="12" font="1">validation. </text>
</page>
<page number="3" position="absolute" top="0" left="0" height="612" width="792">
	<fontspec id="3" size="22" family="Times" color="#000000"/>
	<fontspec id="4" size="8" family="Times" color="#000000"/>
	<fontspec id="5" size="10" family="Times" color="#000000"/>
<text top="70" left="199" width="395" height="27" font="3">Antibody 1277-1 (ELK1) Immunoblot/</text>
<text top="98" left="289" width="215" height="27" font="3">immunoprecipitation </text>
<text top="127" left="389" width="7" height="27" font="3"> </text>
<text top="289" left="557" width="8" height="11" font="1">3 </text>
<text top="289" left="475" width="28" height="11" font="1">Lane: </text>
<text top="161" left="475" width="42" height="11" font="1">MW (kD) </text>
<text top="197" left="482" width="19" height="11" font="1">100 </text>
<text top="211" left="485" width="14" height="11" font="1">75 </text>
<text top="232" left="485" width="14" height="11" font="1">50 </text>
<text top="248" left="485" width="14" height="11" font="1">38 </text>
<text top="177" left="482" width="19" height="11" font="1">150 </text>
<text top="267" left="485" width="14" height="11" font="1">25 </text>
<text top="289" left="508" width="27" height="11" font="1">1  2 </text>
<text top="289" left="574" width="8" height="11" font="1">4 </text>
<text top="162" left="400" width="29" height="27" font="3">B. </text>
<text top="315" left="83" width="626" height="11" font="4"><b>A.</b>  Western blot using 1277-1. Lanes contain nuclear lysates from GM12878 cells (Lane 1), K562 cells (Lane 2), HeLa S3 cells (Lane 3), and </text>
<text top="327" left="83" width="637" height="11" font="1">HepG2 cells (Lane 4).   <b>B.  </b>Immunoprecipitation of ELK1 from K562 cells using 1277-1.  Lane 1: input nuclear lysate, Lane 2:  unbound material </text>
<text top="339" left="83" width="646" height="11" font="1">from immunoprecipitation with AF4185, Lane 3: material immunoprecipitated with 1277-1, Lane 4: material immunoprecipitated using control IgG.  </text>
<text top="283" left="199" width="95" height="11" font="1">Lane     1     2    3    4</text>
<text top="281" left="293" width="7" height="13" font="5"><b>  </b></text>
<text top="192" left="219" width="19" height="11" font="1">100 </text>
<text top="203" left="225" width="14" height="11" font="1">75 </text>
<text top="223" left="225" width="14" height="11" font="1">50 </text>
<text top="236" left="225" width="14" height="11" font="1">38 </text>
<text top="174" left="219" width="19" height="11" font="1">150 </text>
<text top="255" left="225" width="14" height="11" font="1">25 </text>
<text top="161" left="215" width="42" height="11" font="1">MW (kD) </text>
<text top="162" left="179" width="29" height="27" font="3">A. </text>
</page>
<page number="4" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="698" left="268" width="68" height="10" font="1">Submit by Email</text>
<text top="43" left="130" width="399" height="12" font="1">Immunoprecipitation of ELK1 from K562 cells using 1277-1.  Lane 1: input nuclear lysate, Lane 2: </text>
<text top="55" left="130" width="413" height="12" font="1">material immunoprecipitated with 1277-1, Lane 3: material immunoprecipitated using control IgG.  </text>
<text top="67" left="130" width="328" height="12" font="1">Band A was excised from the gel and subject to analysis by mass spectrometry. </text>
<text top="79" left="130" width="2" height="12" font="1"> </text>
<text top="91" left="130" width="403" height="12" font="1">IP followed by mass spectrometry: Briefly, protein was immunoprecipitated from K562 whole cell </text>
<text top="103" left="130" width="409" height="12" font="1">lysates using 1277-1, and the IP fraction was loaded on a 10% polyacrylamide gel (NuPAGE Bis-Tris </text>
<text top="115" left="130" width="422" height="12" font="1">Gel) and separated with an Invitrogen NuPAGE electrophoresis system. The gel was silver-stained, gel </text>
<text top="127" left="130" width="411" height="12" font="1">fragments corresponding to the bands indicated were excised and destained using the SilverSNAP </text>
<text top="139" left="130" width="393" height="12" font="1">Stain for Mass Spectrometry (Pierce). Then proteins were trypsinized using the in-gel digestion </text>
<text top="152" left="130" width="370" height="12" font="1">method. Digested proteins were analyzed on an LTQ-Orbitrap (Thermo Scientific) by the  </text>
<text top="164" left="130" width="423" height="12" font="1">nanoLC-ESI-MS/MS technique. Peptides were identified by  the SEQUEST algorithm and filtered with a </text>
<text top="176" left="130" width="397" height="12" font="1">high confidence threshold (Protein false discovery rate &lt; 1%, 2 peptides per protein minimum). </text>
<text top="188" left="130" width="2" height="12" font="1"> </text>
<text top="200" left="130" width="384" height="12" font="1">We report 32 proteins identified in band A, although 20 of these are also present in a control </text>
<text top="212" left="130" width="424" height="12" font="1">immunoprecipitation and are thus likely to present due to non-specific association with the IP matrix.  </text>
<text top="224" left="130" width="418" height="12" font="1">Of the specifically immunoprecipitated proteins, ELK1 is the second most abundant (5 peptides) and </text>
<text top="236" left="130" width="224" height="12" font="1">is the only one known to be chromosome-associated. </text>
<text top="248" left="130" width="2" height="12" font="1"> </text>
<text top="260" left="130" width="421" height="12" font="1">Based on these observations, this band is likely due to the presence of immunoprecipitated ELK1 and </text>
<text top="272" left="130" width="278" height="12" font="1">1277-1 meets the ENCODE standard for validation by this criterion. </text>
<text top="284" left="130" width="2" height="12" font="1"> </text>
</page>
<page number="5" position="absolute" top="0" left="0" height="612" width="792">
	<fontspec id="6" size="26" family="Times" color="#000000"/>
	<fontspec id="7" size="14" family="Times" color="#000000"/>
	<fontspec id="8" size="14" family="Times" color="#000000"/>
	<fontspec id="9" size="12" family="Times" color="#000000"/>
	<fontspec id="10" size="10" family="Times" color="#000000"/>
<text top="91" left="124" width="450" height="34" font="6">1277‐1 (ELK1) Immunoprecipitation/ </text>
<text top="125" left="231" width="236" height="31" font="6">Mass spectrometry</text>
<text top="129" left="461" width="7" height="27" font="3"> </text>
<text top="159" left="342" width="7" height="27" font="3"> </text>
<text top="179" left="237" width="93" height="20" font="7">ELK1<b> </b>(1277‐1) </text>
<text top="184" left="186" width="21" height="15" font="5"><b>MW</b></text>
<text top="180" left="207" width="4" height="20" font="7"> </text>
<text top="212" left="185" width="23" height="13" font="5"><b>250 </b></text>
<text top="240" left="185" width="23" height="13" font="5"><b>150 </b></text>
<text top="261" left="185" width="23" height="13" font="5"><b>100 </b></text>
<text top="281" left="188" width="17" height="13" font="5"><b>75 </b></text>
<text top="308" left="188" width="17" height="13" font="5"><b>50 </b></text>
<text top="331" left="188" width="17" height="13" font="5"><b>37 </b></text>
<text top="355" left="188" width="17" height="13" font="5"><b>25 </b></text>
<text top="393" left="188" width="17" height="13" font="5"><b>10 </b></text>
<text top="421" left="161" width="35" height="16" font="9">Lane </text>
<text top="421" left="231" width="121" height="16" font="9">1              2           3</text>
<text top="419" left="352" width="4" height="20" font="7"> </text>
<text top="208" left="403" width="105" height="13" font="10">Lane 1 Input lysate </text>
<text top="222" left="403" width="166" height="13" font="10">Lane 2 Bound material from IP </text>
<text top="236" left="403" width="203" height="13" font="10">Lane 3 Bound material from IP            </text>
<text top="251" left="443" width="119" height="13" font="10">using non-specific IgG</text>
<text top="246" left="562" width="4" height="20" font="7"> </text>
<text top="296" left="378" width="42" height="13" font="5"><b>Band A</b></text>
<text top="292" left="420" width="4" height="18" font="8"><b> </b></text>
</page>
<page number="6" position="absolute" top="0" left="0" height="612" width="792">
<text top="73" left="66" width="45" height="12" font="1">Spectrum </text>
<text top="73" left="200" width="72" height="12" font="1">Name of Protein</text>
<text top="73" left="354" width="164" height="12" font="1">Peptide count Ratio(ELK1/IgG control)</text>
<text top="87" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="86" left="174" width="124" height="11" font="1">Isoform 1 of Serum albumin</text>
<text top="88" left="381" width="6" height="11" font="1">9</text>
<text top="87" left="463" width="13" height="12" font="1">4.5</text>
<text top="101" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="100" left="161" width="149" height="11" font="1">Heat shock 70 kDa protein 1A/1B</text>
<text top="102" left="381" width="6" height="11" font="1">6</text>
<text top="101" left="429" width="81" height="12" font="1">NOT IN CONTROL IP</text>
<text top="115" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="114" left="207" width="58" height="11" font="1">Tubulin, beta</text>
<text top="115" left="381" width="6" height="11" font="1">6</text>
<text top="115" left="467" width="5" height="12" font="1">1</text>
<text top="129" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="128" left="154" width="164" height="11" font="1">Interleukin enhancer-binding factor 2</text>
<text top="129" left="381" width="6" height="11" font="1">5</text>
<text top="129" left="458" width="23" height="12" font="1">0.625</text>
<text top="143" left="56" width="290" height="12" font="1">ELK1_Band A Isoform 1 of ETS domain-containing protein Elk-1</text>
<text top="143" left="381" width="6" height="11" font="1">5</text>
<text top="143" left="429" width="81" height="12" font="1">NOT IN CONTROL IP</text>
<text top="156" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="156" left="163" width="145" height="11" font="1">Putative uncharacterized protein</text>
<text top="157" left="381" width="6" height="11" font="1">5</text>
<text top="157" left="429" width="81" height="12" font="1">NOT IN CONTROL IP</text>
<text top="170" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="170" left="185" width="101" height="11" font="1">Alpha-2-macroglobulin</text>
<text top="171" left="381" width="6" height="11" font="1">4</text>
<text top="171" left="429" width="81" height="12" font="1">NOT IN CONTROL IP</text>
<text top="184" left="56" width="292" height="12" font="1">ELK1_Band A cDNA FLJ54533, highly similar to Heterogeneous </text>
<text top="195" left="174" width="123" height="11" font="1">nuclear ribonucleoprotein H</text>
<text top="196" left="381" width="6" height="11" font="1">4</text>
<text top="196" left="443" width="54" height="12" font="1">0.571428571</text>
<text top="210" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="209" left="175" width="120" height="11" font="1">Elongation factor 1-alpha 1</text>
<text top="210" left="381" width="6" height="11" font="1">4</text>
<text top="210" left="467" width="5" height="12" font="1">4</text>
<text top="223" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="223" left="199" width="74" height="11" font="1">Protein S100-A9</text>
<text top="224" left="381" width="6" height="11" font="1">4</text>
<text top="224" left="429" width="81" height="12" font="1">NOT IN CONTROL IP</text>
<text top="237" left="56" width="290" height="12" font="1">ELK1_Band A cDNA FLJ53910, highly similar to Keratin, type II </text>
<text top="248" left="202" width="68" height="11" font="1">cytoskeletal 6A</text>
<text top="249" left="381" width="6" height="11" font="1">3</text>
<text top="249" left="443" width="54" height="12" font="1">0.214285714</text>
<text top="263" left="56" width="290" height="12" font="1">ELK1_Band A cDNA FLJ55805, highly similar to Keratin, type II </text>
<text top="273" left="205" width="61" height="11" font="1">cytoskeletal 4</text>
<text top="275" left="381" width="6" height="11" font="1">3</text>
<text top="274" left="467" width="5" height="12" font="1">3</text>
<text top="288" left="56" width="290" height="12" font="1">ELK1_Band A cDNA FLJ60647, highly similar to Keratin, type II </text>
<text top="299" left="202" width="68" height="11" font="1">cytoskeletal 6B</text>
<text top="300" left="381" width="6" height="11" font="1">3</text>
<text top="299" left="463" width="13" height="12" font="1">0.3</text>
<text top="313" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="312" left="165" width="142" height="11" font="1">Eukaryotic initiation factor 4A-III</text>
<text top="314" left="381" width="6" height="11" font="1">3</text>
<text top="313" left="460" width="18" height="12" font="1">0.75</text>
<text top="327" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="326" left="148" width="176" height="11" font="1">Heat shock 70kDa protein 1-like variant</text>
<text top="328" left="381" width="6" height="11" font="1">3</text>
<text top="327" left="429" width="81" height="12" font="1">NOT IN CONTROL IP</text>
<text top="341" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="340" left="210" width="51" height="11" font="1">Hemopexin</text>
<text top="342" left="381" width="6" height="11" font="1">3</text>
<text top="341" left="429" width="81" height="12" font="1">NOT IN CONTROL IP</text>
<text top="355" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="354" left="138" width="196" height="11" font="1">Heterogeneous nuclear ribonucleoprotein G</text>
<text top="355" left="381" width="6" height="11" font="1">3</text>
<text top="355" left="467" width="5" height="12" font="1">1</text>
<text top="369" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="368" left="138" width="194" height="11" font="1">Heterogeneous nuclear ribonucleoprotein K</text>
<text top="369" left="381" width="6" height="11" font="1">3</text>
<text top="369" left="460" width="18" height="12" font="1">0.75</text>
<text top="383" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="382" left="151" width="169" height="11" font="1">Isoform 1 of Alpha-1-antichymotrypsin</text>
<text top="383" left="381" width="6" height="11" font="1">3</text>
<text top="383" left="429" width="81" height="12" font="1">NOT IN CONTROL IP</text>
<text top="396" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="396" left="166" width="140" height="11" font="1">Isoform 1 of Alpha-1-antitrypsin</text>
<text top="397" left="381" width="6" height="11" font="1">3</text>
<text top="397" left="429" width="81" height="12" font="1">NOT IN CONTROL IP</text>
<text top="410" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="410" left="141" width="190" height="11" font="1">Isoform 2 of Keratin, type II cytoskeletal 80</text>
<text top="411" left="381" width="6" height="11" font="1">3</text>
<text top="411" left="467" width="5" height="12" font="1">3</text>
<text top="424" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="424" left="148" width="176" height="11" font="1">Isoform 3 of Glial fibrillary acidic protein</text>
<text top="425" left="381" width="6" height="11" font="1">3</text>
<text top="425" left="467" width="5" height="12" font="1">3</text>
<text top="438" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="438" left="171" width="129" height="11" font="1">Keratin, type II cytoskeletal 8</text>
<text top="439" left="381" width="6" height="11" font="1">3</text>
<text top="438" left="460" width="18" height="12" font="1">0.75</text>
<text top="452" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="452" left="199" width="73" height="11" font="1">TUBA1B protein</text>
<text top="453" left="381" width="6" height="11" font="1">3</text>
<text top="452" left="460" width="18" height="12" font="1">0.75</text>
<text top="466" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="465" left="128" width="218" height="11" font="1">cDNA FLJ50996, highly similar to 60S ribosomal </text>
<text top="477" left="213" width="45" height="11" font="1">protein L4</text>
<text top="478" left="381" width="6" height="11" font="1">2</text>
<text top="478" left="429" width="81" height="12" font="1">NOT IN CONTROL IP</text>
<text top="491" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="491" left="139" width="194" height="11" font="1">Heterogeneous nuclear ribonucleoprotein F</text>
<text top="492" left="381" width="6" height="11" font="1">2</text>
<text top="492" left="443" width="54" height="12" font="1">0.333333333</text>
<text top="505" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="505" left="142" width="188" height="11" font="1">Isoform 3 of Keratin, type I cytoskeletal 13</text>
<text top="506" left="381" width="6" height="11" font="1">2</text>
<text top="505" left="443" width="54" height="12" font="1">0.666666667</text>
<text top="519" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="519" left="142" width="188" height="11" font="1">Peptidyl-prolyl cis-trans isomerase FKBP4</text>
<text top="520" left="381" width="6" height="11" font="1">2</text>
<text top="519" left="429" width="81" height="12" font="1">NOT IN CONTROL IP</text>
</page>
<page number="7" position="absolute" top="0" left="0" height="612" width="792">
<text top="73" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="72" left="157" width="157" height="11" font="1">Polymeric immunoglobulin receptor</text>
<text top="74" left="381" width="6" height="11" font="1">2</text>
<text top="73" left="429" width="81" height="12" font="1">NOT IN CONTROL IP</text>
<text top="87" left="56" width="289" height="12" font="1">ELK1_Band A Ribosome biogenesis regulatory protein homolog</text>
<text top="88" left="381" width="6" height="11" font="1">2</text>
<text top="87" left="463" width="13" height="12" font="1">0.5</text>
<text top="101" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="100" left="220" width="31" height="11" font="1">TDP43</text>
<text top="102" left="381" width="6" height="11" font="1">2</text>
<text top="101" left="467" width="5" height="12" font="1">1</text>
<text top="115" left="56" width="59" height="12" font="1">ELK1_Band A</text>
<text top="114" left="133" width="209" height="11" font="1">U3 small nucleolar RNA-associated protein 15 </text>
<text top="126" left="217" width="39" height="11" font="1">homolog</text>
<text top="127" left="381" width="6" height="11" font="1">2</text>
<text top="126" left="467" width="5" height="12" font="1">1</text>
</page>
</pdf2xml>
